Chlamydial infections of the cardiovascular system

Frontiers in Bioscience

Volumn 8, Issue , 2003, Pages

  Kuo, Cho Chou ^a   Campbell, Lee Ann ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Atherosclerosis; Cardiovascular Disease; Chlamydia Pneumoniae; Chlamydial infection; Review

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CLARITHROMYCIN; MACROLIDE; QUINOLINE DERIVATIVE; RIFAMPICIN; ROXITHROMYCIN; TETRACYCLINE DERIVATIVE;

ANTIGEN DETECTION; ATHEROSCLEROSIS; BACTERIUM DETECTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; PATHOGENESIS; REVIEW; SEROEPIDEMIOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHLAMYDOPHILA PSITTACI;

EID: 3142584228     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Moulder J.W., T.P. Hatch, C-C Kuo, J. Schachter, & J. Storz: Genus Chlamydia, Jones, Rake, and Stearns 1945,55. In N.R. Krieg (ed.), Bergey's Manual of Systematic Bacteriology. Baltimore, MD: Williams and Wilkins. vol 1, 729-739 (1984)
2. Grayston J.T, C-C Kuo, L.A. Campbell & S-P Wang: Chlamydia pneumoniae sp. nov. for Chlamydia strain TWAR. Int J Syst Bacteriol 39, 88-90 (1988)
3. Fukushi H & K. Hirai: Proposal of Chlamydia pecorum sp. nov. for Chlamydia strains derived from ruminants. Int J Syst Bacteriol 42, 306.308 (1992)
4. Beatty W, R.P. Morrison & G.I. Byrne: Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microb Rev 58, 686-699 (1994)
5. Grayston J.T, S-P Wang, L-J Yeh & C-C Kuo: Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis 1, 717-725 (1985)
6. Kuo C-C & L.A. Campbell: Pathologic manifestation of chlamydial infection. Am Heart J 138, S496-S499 (1999)
7. Gilbert D.N. & J.T. Grayston (eds): The potential etiologic role of Chlamydia pneumoniae in atherosclerosis. A multidisciplinary meeting to promote collaborative research. J Infect Dis 181(suppl 3), S393-S586 (2000)
8. Odeh M & A. Oliven: Chlamydial infection of the heart. Eur J Clin Microbiol Infect Dis 11, 885-893 (1992)
9. Saikku P, K. Mattila, M.S. Nieminen, J.K. Huttunen, M. Leinenen, M-R Ekman, P.H. Makela, & V. Valtonen: Serological evidence of an association of a novel Chlamydia TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2, 983-986 (1988)
10. Shor A, C-C Kuo & D.L. Patton: Detection of Chlamydia pneumoniae in coronary artery fatty streaks and atheromatous plaques. S Afr Med J 82, 158-161 (1992)
11. Ramirez J.A. and the Chlamydia pneumoniae/Atherosclerosis study group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 125, 979-982 (1996)
12. Muhlestein J.B, J.L. Anderson, E.H. Hammond, L. Zhao, S. Treharn, E.P. Schwobe & J.F. Carlquist: Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97, 633-636 (1998)
13. Moazed C, L.A. Campbell, M.E. Rosenfeld, J.T. Grayston & C-C Kuo: Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in ApoE-deficient mice. J Infect Dis 180, 238-241 (1999)
14. Campbell L.A, C-C Kuo & J.T. Grayston: Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis 4, 571-579 (1998)
15. Camm A.J. & K.M. Fox: Chlamydia pneumoniae (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence? Eur Heart 721, 1046-1051 (2000)
16. Wong Y-K, P.J. Gallagher & M.E. Ward: Chlamydia pneumoniae and atherosclerosis. Heart 81, 232-238 (1999)
17. Mahoney J, & B. Coombs: Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or confirmatory role? FEMS Microbiol. Lett 197, 1-9 (2001)
18. Leinonen M, E. Linnanmaki, K. Mattila, M.S. Nieminen, V. Valtonen, M. Leirisalo-Repo & P. Saikku: Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog 9, 67-73 (1990)
19. Linnanmaki E, M. Leinonen, K. Mattila, M.S. Nieminen, V. Valtonen V & P. Saikku: Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation 87, 1130-1134 (1993)
20. Thom D.H, S-P Wang, J.T. Grayston, D.S. Siscovick, D.K. Stewart, R.A. Kronmal & N.S. Weiss: Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 11, 547-551 (1991)
21. Thom D.H, J.T. Grayston JT, D.S. Siscovick, S-P Wang, N.S. Weiss & J.R.Daling: Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 268, 68-72 (1992)
22. Ridka P.M, R.B. Kunsin, M.J. Stampfer, S. Poulin & C.H. Hennekens: Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction. Circulation 99, 1161-1164 (1999)
23. Saikku P, M. Leinonen, L. Tenkanen, E. Linnanmaki, M-R Ekman, V. Manninen, M. Manntari, H. Frick & J.K. Huttunen: Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 116, 273-278 (1992)
24. Mendall M.A, D. Carrington, D. Strachan, P. Patel, N. Molineaux, J. Levi, T. Toosey, A.J. Camm & T.C. Northfield: Chlamydia pneumoniae: Risk factors for seropositivity and association with coronary heart disease. J Infect 30, 121-128 (1995)
25. Sessa R, M.D. Pietro, I. Santino, M. del Piano, A. Varveri, A. Dagianti & M. Penco: Chlamydia pneumoniae infection and atherosclerotic coronary disease. Am Heart J 137, 1116-1119 (1999)
26. Kuo C-C, L.A. Jackson, L.A. Campbell & J.T. Grayston: Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8, 451-461 (1995)
27. Melnick S.L, E.E. Shahar, A.R. Folson, J.T. Grayston, P.D. Sorlie, S-P Wang & M. Szklo for the Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Med 95, 499-504 (1993)
28. Lindholt J.S, S. Juul, S. Vammen, I. Lind, H. Fasting & E.W. Henneberg: Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm. British J Surg 86, 634-638 (1999)
29. Blanchard J.F, H.K. Armenian, R. Peeling, P.P. Friesen, C. Shen & R.C. Brunham: The relationship between Chlamydia pneumoniae infection and abdominal aortic aneurysm: Case-control study. Clin Infect Dis 30, 946-947 (2000)
30. Wimmer M.L.J, R. Sandmann-Strupp, P. Saikku & R.L. Haberl: Association of chlamydial infection with cerebrovascular disease. Stroke 227, 2207-2210 (1996)
31. Fagerberg B, J. Gnarpe, H. Gnarpe, S. Agewall & J. Wikstrand: Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease. A prospective study in middle-aged to elderly men with treated hypertension. Stroke 30, 299-305 (1999)
32. Kuo C-C, A. Shor, L.A. Campbell, H. Fukushi, D.L. Patton & J.T. Grayston: Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167, 841-849 (1993)
33. Kuo C-C & L.A. Campbell: Detection of Chlamydia pneumoniae in arterial tissues. J Infect Dis 181 (suppl 3), S432-436 (2000)
34. Taylor-Robinson D. Chlamydia pneumoniae in vascular tissue. Atherosclerosis 1998 140 (suppl 1), S21-S24 (1998)
35. Weiss S.M, P.M. Roblin, C.A. Gaydos, P. Cuminings, D.L. Patton, N. Schulhoff, J. Shani, R. Frankel, K. Penney, T.C. Quinn, M.R. Hammerschlag & J. Schachter: Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173, 957-962 (1996)
36. Patterson D.L, J. Hall J, S.J. Rasmussen & P. Timms: Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients. Pathology 30, 167-172 (1998)
37. Lindholt J.S, L. Ostergard, E.W. Henneberg, H. Fasting & P. Andersen: Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR). Eur J Vasc Endovasc Surg 15, 161-164 (1998)
38. Bartels C, M. Maass, G. Bein, R. Malisius, N. Brill, J.P.M. Bechtel, F. Sayk, A.C. Feller & H-H Sievers: Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts. Circulation 99, 879-882 (1999)
39. Jackson L.A, L.A. Campbell, C-C Kuo, D.I. Rodriguez, A. Lee & J.T. Grayston: Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen. J Infect Dis 176, 292-295 (1997)
40. Kuo C-C, A.S. Coulson, L.A. Campbell, A.L. Cappuccio, R.D. Lawrence, S-P Wang & J.T. Grayston: Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg 26, 29-31 (1997)
41. Blasi F, F. Denti, M. Ebra, R. Cosentini, R. Raccanelli, A. Rinaldi, L. Fagetti, G. Esposito, U. Ruberti & L. Allergra: Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 34, 2766-2769 (1996)
42. Juvonen J, T. Juvonen T, A. Laurila, H. Alakarppa, K. Lounatmaa, H-M Surcel, M. Leinonen, M.I. Kairaluoma & P. Saikku: Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vas Surg 25, 499-505 (1997)
43. Meijer A, A. van der Vliet, P.J.M. Roholl, S.K. Gielis-Proper, A. de Vries & J.M. Ossewaarde: Chlamydia pneumoniae in abdominal aortic aneurysms abundance of membrane components in the absence of heat shock protein 60 and DNA. Arterioscler Thromb Vasc Biol 19, 2680-2686 (1999)
44. Nystrom-Rosander C, S. Thelin, E. Hjelm, O. Lindquist, C. Pahlson & G. Friman: High incidence of Chlamydia pneumoniae in sclerotic heart valves of patients undergoing aortic valve replacement. Scand J Infect Dise 29, 361-365 (1997)
45. Juvonen J, A. Laurila, T. Juvonen, H. Alakarppa, H-M Surcel, K. Lounatmaa, J. Kuusisto & P. Saikku : Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves. J Am Coll Cardiol 29, 1054-1059 (1997)
46. Juvonen J, T. Juvonen, A. Laurila, J. Kuusisto, E. Alarakkola, T. Sarkioja, C.A. Bodian, M.I. Kairaluoma & P. Saikku: Can degenerative aortic valve stenosis be related to persistent Chlamydia pneumoniae infection? Ann Intern Med 128, 741-744 (1998)
47. Andersen J.J, S. Farholt & J.S. Jensen: Failure to detect Chlamydia pneumoniae in calcific and degenerative arteriosclerotic aortic valves excised during open heart surgery. APMIS 106, 717-720 (1998)
48. Taylor-Robinson D, G. Ong, B.J. Thomas, M.L. Rose & M.H. Yacoub: Chlamydia pneumoniae in vascular tissues from heart-transplant donors. Lancet 351, 1255 (1998)
49. Kuo C-C, J.T. Grayston, L.A. Campbell, Y.A. Goo, R.W. Wissler & E.P. Benditt: Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA 92, 6911-6914 (1995)
50. Davidson M, C-C Kuo, J.P. Middaugh, L.A. Campbell, S-PWang S-P, W.P. III. Newman, J.C. Finley & J.T. Grayston: Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation 98, 628-633 (1998)
51. Maass M, Gieffers J, Krause E, Engel PM, Bartels C, Solbach W. Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients. Med Microbiol Immunol 187, 103-106 (1998)
52. Maass M, C. Bartels, P.M. Engel, U. Mamat & H-H Sievers: Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 31, 827-832 (1998)
53. Bartels C, M. Maass, G. Bein, N. Brill, J.F.M. Bechtel, R. Leyh & H-H Sievers: Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease. Circulation 101, 137-141 (2000)
54. Boman J, S. Soderberg, J. Forsberg, L.S. Birgander, A. Allard, K. Persson, E. Jidell, U. Kumlin, P. Juto, A. Waldenstrom & G. Wadell: High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors. J Infect Dis 178, 274-277 (1998)
55. Wong Y-k, K.D. Dawkins & M.E. Ward: Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease. J Am Coll Cardiol 34, 1435-1439 (1999)
56. Giefers J, H. Fullgraf, J. Jahn, M. Kinger, K. Dalhoff, H.A. Katus, W. Solbach & M. Maass: Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 103, 351-356 (2001)
57. Blasi F, J. Boaman, G. Esposito, G. Mellsano, R. Chiesa, R. Cosentini, P. Tarsia, Y. Tshomba, M. Betti, M. Alessi, N. Morelli & L. Allegra: Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J Infect Dis 180, 2074-2076 (1999)
58. Bodetti T.J & P. Timms: Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of human and koalas. Infect Immun 68, 2744-2747 (2000)
59. Haranaga S, H. Yamaguchi, G.F. Leparc, H. Fiedman & Y. Yamamoto: Detection of Chlamydia pneumoniae antigen in PBMCs of healthy blood donors. Transfusion 41, 1114-1119 (2001)
60. Kuo C-C & L.A. Campbell: Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis? Mol Med Today 4, 426-430 (1998)
61. Kuo C-C, A.M. Gown, E.P. Benditt & J.T. Grayston: Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 13, 1501-1504 (1993)
62. Yamashita K, K. Ouchi, M. Shirai, T. Gondo, T. Nakazawa & H. Ito: Distribution of Chlamydia pneumoniae infection in the athrosclerotic carotid artery. Stroke 29, 773-778 (1998)
63. Kalayoglu M.V & G.S. Bryne: Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 111, 725-729 (1998)
64. Kalayoglu M.V, Indrawati, R.P. Morrison, S.G. Morrison, Y. Yuan & G.I. Bryne: Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophages- interactions. J Infect Dis 181 (suppl 3), S483-S489 (2000)
65. Kol A, G.K. Sukhova, A.H. Lichtman & P. Libby: Chlamydial heat shock protein 60 localized-human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. Circulation 98, 300-307 (1998)
66. Lin T-M, L.A. Campbell, M.E. Rosenfeld & C-C Kuo: Monocyte-endothelial cell coculture enhances infection of endothelial cells with Chlamydia pneumoniae. J Infect Dis 181, 1096-1000 (2000)
67. th International Symposium on Human Chlamydial Infections, held in Antalya, Turkey, June 16-21, 2002.
68. Lin T-M, L.A. Campbell, M.E. Rosenfeld & C-C Kuo: Human monocyte-derived insulin-like growth factor-2 enhances the infection of human arterial endothelial cells by Chlamydia pneumoniae. J Infect Dis 183, 1368-1372 (2001)
69. Burnet M.S, C.A. Gaydos, G.E. Madico, S.M. Glad, B. Paigen & T.C. Quinn & S.E. Epstein: Atherosclerosis in apoE knockout mice infected with multiple pathogens. J Infect Dis 183, 226-231 (2001)
70. Hu H, G.N. Pierce & G. Zhong: The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 103, 747-753 (1999)
71. Blessing E, L.A. Campbell, M.E. Rosenfeld, N. Cough & C-C Kuo: Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 158, 13-17 (2001)
72. Fong I.W, B. Chiu, E. Viira, D. Jang & J.B. Mahony: De novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model. Infect Immun 11, 6048-6055 (1999)
73. Caliguri G, M. Rottenberg, A. Nicoletti, H. Wigzell & G. Hansson: Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice. Circulation 103, 2834-2838 (2001)
74. Blessing E, T-M Lin, L.A. Campbell, M.E. Rosenfeld, D. Lloyd & C-C Kuo: Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normolipidemic C57BL/6J mice. Infect Immun 68, 4765-4768 (2000)
75. Laitinen K, A. Laurila, L. Pyhala, M. Leinonen & P. Saikku: Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun 65, 4832-4835 (1997)
76. Fong I.W, B. Chiu, E. Viira, D. Jang, M.W. Fond, R. Peeling & J.B. Mahoney: Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in rabbit model? Clin Diag Lab Immunol 6, 851-894 (1999)
77. Rothstein N.M, T.C. Quinn, G. Madico, C.A. Gaydos & C.J. Lowenstein: Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. J Infect Dis 183, 232-238 (2001)
78. Gupta S, E.W. Leatham, D. Carrington, M.A. Mendall, J.C. Kaski & A.J. Camm: Elevated Chlamydia pneumoniae antibodies, cardiovascular events and azithromycin in male survivors of myocardial infarction. Circulation 46, 404-407 (1997)
79. Gurfinkel E, G. Bozovich, E. Beck, E. Testa, B. Livellara & B. Mautner for the ROXIS Study Group. Treatment with the antibiotic roxithromcyin in patients with acute non-Q-wave coronary syndromes. The final report of the ROXIS Study. Eur Heart J 20, 121-127 (1999)
80. Muhlestein J.B, J.L. Anderson, J.F. Carlquist, K. Salunke, B.D. Home, R.R. Pearson, T.J. Bunch, A. Allen, S. Trehan & C. Nelson: Randomized secondary prevention trial of azithromycin with coronary artery disease. Primary clinical results of the ACADEMIC study. Circulation 102, 1755-1760 (2000)
81. Sinisalo J, K. Mattila, V. Valtonen, O. Anttonen, J. Juvonen, J. Melin, H. Vuorinen-Markkola & M.S. Nieminen for the Clarithromycin in acute coronary syndrome patients in Finland (CLARIFY) Study Group. Effect of 3 months of antimicrobial treatment with Clarithromycin in acute non-Q-wave coronary syndrome. Circulation 105, 1555-1560 (2002)
82. Dunne M.W. Rationale and design of a secondary prevention trial of antibiotic use in patients after myocardial infarction: The WIZARD (Weekly Intervention with Zithromax (Azithromycin) for atherosclerosis and its related disorders) trial. J Infect Dis 181 (suppl 3), S572-578 (2000)
83. Jackson L.A. Description and status of the azithromycin and coronary event study (ACES). J Infect Dis 181 (suppl 3), S579-581 (2000)